Stock VIVE VIVESTO AB
Add to a list
To use this feature you must be a member
Log inSign up

All News Vivesto AB

Equities

VIVE

SE0000722365

Delayed Nasdaq Stockholm
Other stock markets
 07:06:33 2024-05-21 am EDT 		5-day change 1st Jan Change
0.2995 SEK +3.28% Intraday chart for Vivesto AB -0.17% -26.50%
Mar. 26 Transcript : Vivesto AB - Special Call
Mar. 07 Vivesto AB Doses First Patient in its Clinical Paccal Vet Trial CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Notice of Annual General Meeting in Vivesto AB
AQ
Transcript : Vivesto AB - Special Call
Vivesto to hold live-streamed Paccal Vet R&D Update on March 26
AQ
Vivesto doses first patient in its clinical Paccal Vet trial
AQ
Vivesto AB Doses First Patient in its Clinical Paccal Vet Trial
CI
Vivesto AB Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Vivesto's international patent application for XR-18 receives positive decision
AQ
Vivesto's International Patent Application for XR-18 Receives Positive Decision
CI
Vivesto Gains on Receipt of US Approval for Pilot Clinical Trial of Drug Candidate Paccal Vet
MT
Vivesto’s US clinical Paccal Vet trial receives approval to start patient recruitment
AQ
Vivesto AB's US Clinical Paccal Vet Trial Receives Approval to Start Patient Recruitment
CI
Vivesto’s Paccal Vet granted FDA MUMS designation
AQ
Vivesto makes impairment charge following withdrawal of European market authorizations for Apealea
AQ
Vivesto AB Reports Positive Preclinical Data Supporting Continued Development of Cantrixil
CI
Vivesto reports positive preclinical data supporting continued development of Cantrixil
AQ
Nomination Committee appointed for the 2024 Annual General Meeting in Vivesto
AQ
Vivesto AB Announces Composition of Nomination Committee
CI
Vivesto Abandons Apealea Partnership with Elevar Therapeutics
MT
Vivesto and Elevar sign agreement ending Apealea® partnership
AQ
Vivesto AB and Elevar Therapeutics Inc. Sign Agreement Ending Apealea®? Partnership
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. VIVE Stock
  4. News Vivesto AB
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW